KALA BIO
KALA · NASDAQ
$0.1897−$0.0029 (−1.51%)TodayMarket closed ·
Prev close $0.1926
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 29.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q4 FY25 | -$73.44 | -$33.50 | +54.4% |
| Q3 FY25 | -$73.72 | -$43.00 | +41.7% |
| Q2 FY25 | -$86.87 | -$85.50 | +1.6% |
| Q1 FY25 | -$103.53 | -$70.50 | +31.9% |
| Q4 FY24 | -$116.28 | -$87.00 | +25.2% |
| Q3 FY24 | -$123.93 | -$96.50 | +22.1% |
| Q2 FY24 | -$224.65 | -$158.00 | +29.7% |
| Q1 FY24 | -$147.39 | -$209.50 | −42.1% |
Earnings calls
- Special Call - KALA BIO, Inc.
- KALA - Earnings call Q2 2022
- KALA - Earnings call Q1 2022
- KALA - Earnings call Q4 2021
- KALA - Earnings call Q3 2021
- KALA - Earnings call Q2 2021
- BofA Securities 2021 Virtual Health Care Conference
- KALA - Earnings call Q1 2021
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.